Correction: Anti-osteosarcoma effect of hydroxyapatite nanoparticles both: In vitro and in vivo by downregulating the FAK/PI3K/Akt signaling pathway (Biomaterials Science (2020) 8 (4426–4437) DOI: 10.1039/D0BM00898B)

Abstract

Correction for 'Anti-osteosarcoma effect of hydroxyapatite nanoparticles both in vitro and in vivo by downregulating the FAK/PI3K/Akt signaling pathway' by Renxian Wang et al., Biomater. Sci., 2020, 8, 4426-4437, DOI: 10.1039/D0BM00898B. The authors regret that the caption for Fig. 6 of the published manuscript was incorrect. The correct version is shown below. The figure of ‘H&E staining of lung, liver and kidney tissues from xenograft-bearing mice’ can be found in the ESI of the published manuscript. The authors note that this correction has no effect on the results reported, nor does this change any of the contents and conclusions of the paper. The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.